Grants and Contributions:
Title:
UK BioM-10139996-PHAGOPRODUCTION-GMP compliant large scale biomanufacturing of bacteriophages to tackle AMR care continuum from diagnosis to therapy
Agreement Number:
1029004
Agreement Value:
$592,499.00
Agreement Date:
Apr 1, 2025 - Mar 30, 2027
Description:
This Canada-UK collaborative project aims to establish large-scale, GMP (Good Manufacturing Practices)-compliant manufacturing of bacteriophages to combat antimicrobial-resistant infections. Using an innovative bioreactor, the team will scale up production for several phage candidates targeting WHO-priority pathogens. The project integrates innovative technologies for phage characterization and rapid diagnostic testing.
Organization:
National Research Council Canada
Expected Results:
The expected results and outcomes of NRC Industrial Research Assistance Program is focused on growing small and medium-sized enterprises (SMEs) through innovation and wealth creation for Canada.
Location:
Gatineau, Quebec, CA J9J 3K3
Reference Number:
172-2025-2026-Q1-1029004
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
789858214
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 2 time(s). The total amended value is 92,500 dollars.
Amendment Date
Mar 30, 2026
Recipient's Legal Name:
Qeen Biotechnologies Inc.
Federal Riding Name:
Pontiac
Federal Riding Number:
24057
Program:
Industrial Research Assistance Program
Program Purpose:
The purpose of Industrial Research Assistance Program Contributions to Firms is to provide support that assists small and medium-sized enterprises (SMEs) to advance their innovation knowledge and ability to innovate, grow through innovation and stimulate wealth creation for Canada.
Coverage:
Industrial Research Assistance Program projects stimulate wealth creation for Canada through technological innovation and strengthen Canadian innovation ecosystem by creating new industrial capacity.
NAICS Code:
541710
Amendments: